UNITED STATES

OMB APPROVAL

 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

OMB Number:  3235-0582

 

Expires:  January 31, 2015

 

Estimated average burden hours per response........9.6

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number  811- 06565

 

H&Q Life Sciences Investors

(Exact name of registrant as specified in charter)

 

2 Liberty Square, 9th Floor, Boston, MA

 

02109

(Address of principal executive offices)

 

(Zip code)

 

Laura Woodward

H&Q Life Sciences Investors

2 Liberty Square, 9th Floor, Boston MA 02109

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:  617-772-8500

 

 

Date of fiscal year end:  September 30

 

 

Date of reporting period:  7/1/13-6/30/14

 

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4).  The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public.  A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number.  Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC  20549-0609.  The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

 

 

 


 

Item 1. Proxy Voting Record.

 


 

Vote Summary

 

A.P. PHARMA, INC.

 

Security

00202J203

Meeting Type

Special

Ticker Symbol

APPA

Meeting Date

19-Sep-2013

Record Date

20-Aug-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO APPROVE AN AMENDMENT TO THE COMPANY’S CERTIFICATE OF INCORPORATION TO IMPLEMENT A REVERSE STOCK SPLIT, WITHIN A RANGE FROM 1-FOR-10 TO 1-FOR-20, WITH THE EXACT RATIO OF THE REVERSE STOCK SPLIT TO BE DETERMINED BY THE BOARD OF DIRECTORS OF THE COMPANY.

 

Management

 

For

 

For

 

2.

 

TO APPROVE AND ADOPT AN AMENDMENT TO THE COMPANY’S CERTIFICATE OF INCORPORATION, AS AMENDED, TO CHANGE THE NAME OF THE COMPANY FROM A.P. PHARMA, INC. TO “HERON THERAPEUTICS, INC.”

 

Management

 

For

 

For

 

 

ACCURAY INCORPORATED

 

Security

004397105

Meeting Type

Annual

Ticker Symbol

ARAY

Meeting Date

21-Nov-2013

Record Date

04-Oct-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A

 

ELECTION OF DIRECTOR: ROBERT S. WEISS

 

Management

 

For

 

For

 

1B

 

ELECTION OF DIRECTOR: RICHARD PETTINGILL

 

Management

 

For

 

For

 

2

 

ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS (SAY-ON-PAY VOTE).

 

Management

 

For

 

For

 

3

 

TO RATIFY THE APPOINTMENT OF GRANT THORNTON LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2014.

 

Management

 

For

 

For

 

 

ACORDA THERAPEUTICS, INC.

 

Security

00484M106

Meeting Type

Annual

Ticker Symbol

ACOR

Meeting Date

05-Jun-2014

Record Date

08-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

RON COHEN, M.D.

 

 

 

For

 

For

 

 

 

2

LORIN J. RANDALL

 

 

 

For

 

For

 

 

 

3

STEVEN M. RAUSCHER

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

3.

 

AN ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

 

ACTAVIS PLC

 

Security

G0083B108

Meeting Type

Annual

Ticker Symbol

ACT

Meeting Date

09-May-2014

Record Date

14-Mar-2014

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: PAUL M. BISARO

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: JAMES H. BLOEM

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: CHRISTOPHER W. BODINE

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: TAMAR D. HOWSON

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: JOHN A. KING

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: CATHERINE M. KLEMA

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: JIRI MICHAL

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: SIGURDUR OLI OLAFSSON

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: PATRICK J. O’SULLIVAN

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: RONALD R. TAYLOR

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: ANDREW L. TURNER

 

Management

 

For

 

For

 

1L.

 

ELECTION OF DIRECTOR: FRED G. WEISS

 

Management

 

For

 

For

 

2.

 

TO APPROVE, ON AN ADVISORY BASIS, NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

 

Management

 

For

 

For

 

4.

 

TO VOTE ON A SHAREHOLDER PROPOSAL REQUESTING THE COMPANY TO ISSUE A SUSTAINABILITY REPORT.

 

Shareholder

 

Against

 

For

 

 

ACTAVIS PLC

 

Security

G0083B108

Meeting Type

Special

Ticker Symbol

ACT

Meeting Date

17-Jun-2014

Record Date

02-May-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

APPROVING THE ISSUANCE OF ORDINARY SHARES PURSUANT TO THE AGREEMENT AND PLAN OF MERGER, DATED FEBRUARY 17, 2014, AMONG ACTAVIS PLC (ACTAVIS), FOREST LABORATORIES, INC. (FOREST), TANGO US HOLDINGS INC., TANGO MERGER SUB 1 LLC AND TANGO MERGER SUB 2 LLC (THE ACTAVIS SHARE ISSUANCE PROPOSAL).

 

Management

 

For

 

For

 

2

 

APPROVING ANY MOTION TO ADJOURN THE ACTAVIS EXTRAORDINARY GENERAL MEETING (THE ACTAVIS EGM), OR ANY ADJOURNMENTS THEREOF, TO ANOTHER TIME OR PLACE IF NECESSARY OR APPROPRIATE TO, AMONG OTHER THINGS, SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE ACTAVIS EGM TO APPROVE THE ACTAVIS SHARE ISSUANCE PROPOSAL.

 

Management

 

For

 

For

 

 

ACTAVIS, INC.

 

Security

00507K103

Meeting Type

Special

Ticker Symbol

ACT

Meeting Date

10-Sep-2013

Record Date

30-Jul-2013

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO APPROVE THE TRANSACTION AGREEMENT, DATED MAY 19, 2013, AMONG ACTAVIS, INC. (“ACTAVIS”), WARNER CHILCOTT PUBLIC LIMITED COMPANY (“WARNER CHILCOTT”), ACTAVIS LIMITED (“NEW ACTAVIS”), ACTAVIS IRELAND HOLDING LIMITED, ACTAVIS W.C. HOLDING LLC, AND ACTAVIS W.C. HOLDING 2 LLC AND THE MERGER.

 

Management

 

For

 

For

 

2.

 

TO APPROVE THE CREATION OF DISTRIBUTABLE RESERVES, BY REDUCING ALL OF THE SHARE PREMIUM OF NEW ACTAVIS RESULTING FROM THE ISSUANCE OF NEW ACTAVIS ORDINARY SHARES PURSUANT TO THE SCHEME OF ARRANGEMENT BY WHICH NEW ACTAVIS WILL ACQUIRE WARNER CHILCOTT.

 

Management

 

For

 

For

 

3.

 

TO CONSIDER AND VOTE UPON, ON A NON- BINDING ADVISORY BASIS, SPECIFIED COMPENSATORY ARRANGEMENTS BETWEEN ACTAVIS AND ITS NAMED EXECUTIVE OFFICERS RELATING TO THE TRANSACTION AGREEMENT.

 

Management

 

For

 

For

 

4.

 

TO APPROVE ANY MOTION TO ADJOURN ACTAVIS MEETING, OR ANY ADJOURNMENTS THEREOF, (I) TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF ACTAVIS MEETING TO APPROVE TRANSACTION AGREEMENT & MERGER, (II) TO PROVIDE TO ACTAVIS HOLDERS ANY SUPPLEMENT OR AMENDMENT TO JOINT PROXY STATEMENT (III) TO DISSEMINATE ANY OTHER INFORMATION WHICH IS MATERIAL.

 

Management

 

For

 

For

 

 

AEGERION PHARMACEUTICALS, INC.

 

Security

00767E102

Meeting Type

Annual

Ticker Symbol

AEGR

Meeting Date

25-Jun-2014

Record Date

28-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

SOL J. BARER, PH.D

 

 

 

For

 

For

 

 

 

2

A.M. GOTTO, JR, MD, PHD

 

 

 

For

 

For

 

2.

 

TO APPROVE, IN AN ADVISORY (NON- BINDING) VOTE, AEGERION PHARMACEUTICALS, INC.’S EXECUTIVE COMPENSATION AS DISCLOSED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS AEGERION PHARMACEUTICALS, INC.’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 

AKORN, INC.

 

Security

009728106

Meeting Type

Annual

Ticker Symbol

AKRX

Meeting Date

02-May-2014

Record Date

07-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JOHN N. KAPOOR, PHD

 

 

 

For

 

For

 

 

 

2

RONALD M. JOHNSON

 

 

 

For

 

For

 

 

 

3

BRIAN TAMBI

 

 

 

For

 

For

 

 

 

4

STEVEN J. MEYER

 

 

 

For

 

For

 

 

 

5

ALAN WEINSTEIN

 

 

 

For

 

For

 

 

 

6

KENNETH S. ABRAMOWITZ

 

 

 

For

 

For

 

 


 

 

 

7

ADRIENNE L. GRAVES, PHD

 

 

 

For

 

For

 

2.

 

PROPOSAL TO RATIFY THE SELECTION OF KPMG LLP TO SERVE AS AKORN’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

3.

 

PROPOSAL TO APPROVE THE ADOPTION OF THE AKORN, INC. 2014 STOCK OPTION PLAN.

 

Management

 

For

 

For

 

4.

 

SAY ON PAY - AN ADVISORY VOTE ON APPROVAL OF THE COMPANY’S EXECUTIVE COMPENSATION PROGRAM.

 

Management

 

For

 

For

 

 

ALEXION PHARMACEUTICALS, INC.

 

Security

015351109

Meeting Type

Annual

Ticker Symbol

ALXN

Meeting Date

05-May-2014

Record Date

17-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: LEONARD BELL

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: MAX LINK

 

Management

 

For

 

For

 

1.3

 

ELECTION OF DIRECTOR: WILLIAM R. KELLER

 

Management

 

For

 

For

 

1.4

 

ELECTION OF DIRECTOR: JOHN T. MOLLEN

 

Management

 

For

 

For

 

1.5

 

ELECTION OF DIRECTOR: R. DOUGLAS NORBY

 

Management

 

For

 

For

 

1.6

 

ELECTION OF DIRECTOR: ALVIN S. PARVEN

 

Management

 

For

 

For

 

1.7

 

ELECTION OF DIRECTOR: ANDREAS RUMMELT

 

Management

 

For

 

For

 

1.8

 

ELECTION OF DIRECTOR: ANN M. VENEMAN

 

Management

 

For

 

For

 

02.

 

APPROVAL OF A NON-BINDING ADVISORY VOTE OF THE 2013 COMPENSATION PAID TO ALEXION’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

03.

 

RATIFICATION OF APPOINTMENT BY THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS ALEXION’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

 

Management

 

For

 

For

 

04.

 

TO ACT ON A SHAREHOLDER PROPOSAL REQUESTING THE BOARD TO ADOPT A RULE TO REDEEM ANY CURRENT OR FUTURE SHAREHOLDER RIGHTS PLAN OR AMENDMENT UNLESS SUCH PLAN IS SUBMITTED TO A SHAREHOLDER VOTE WITHIN 12 MONTHS.

 

Shareholder

 

Against

 

For

 

 

ALKERMES PLC

 

Security

G01767105

Meeting Type

Annual

Ticker Symbol

ALKS

Meeting Date

01-Aug-2013

Record Date

10-Jun-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: DAVID W. ANSTICE

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: ROBERT A. BREYER

 

Management

 

For

 

For

 

1.3

 

ELECTION OF DIRECTOR: WENDY L. DIXON

 

Management

 

For

 

For

 

2.

 

TO APPROVE THE ALKERMES PLC 2011 STOCK OPTION AND INCENTIVE PLAN, AS AMENDED.

 

Management

 

For

 

For

 

3.

 

TO HOLD A NON-BINDING ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

4.

 

TO AUTHORIZE HOLDING THE 2014 ANNUAL GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY AT A LOCATION OUTSIDE OF IRELAND.

 

Management

 

For

 

For

 

 


 

5.

 

TO APPOINT PRICEWATERHOUSECOOPERS AS THE INDEPENDENT AUDITORS OF THE COMPANY AND TO AUTHORIZE THE AUDIT AND RISK COMMITTEE OF THE BOARD OF DIRECTORS TO SET THE AUDITOR’S REMUNERATION.

 

Management

 

For

 

For

 

 

ALKERMES PLC

 

Security

G01767105

Meeting Type

Annual

Ticker Symbol

ALKS

Meeting Date

28-May-2014

Record Date

17-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: PAUL J. MITCHELL

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: RICHARD F. POPS

 

Management

 

For

 

For

 

2.

 

TO HOLD A NON-BINDING ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

TO AUTHORIZE HOLDING THE 2015 ANNUAL GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY AT A LOCATION OUTSIDE OF IRELAND.

 

Management

 

For

 

For

 

4.

 

TO APPOINT PRICEWATERHOUSECOOPERS AS THE INDEPENDENT AUDITORS OF THE COMPANY AND TO AUTHORIZE THE AUDIT AND RISK COMMITTEE OF THE BOARD OF DIRECTORS TO SET THE AUDITOR’S REMUNERATION.

 

Management

 

For

 

For

 

5.

 

TO APPROVE THE ALKERMES PLC 2011 STOCK OPTION AND INCENTIVE PLAN, AS AMENDED.

 

Management

 

For

 

For

 

 

AMGEN INC.

 

Security

031162100

Meeting Type

Annual

Ticker Symbol

AMGN

Meeting Date

15-May-2014

Record Date

17-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A

 

ELECTION OF DIRECTOR: DR. DAVID BALTIMORE

 

Management

 

For

 

For

 

1B

 

ELECTION OF DIRECTOR: MR. FRANK J. BIONDI, JR.

 

Management

 

For

 

For

 

1C

 

ELECTION OF DIRECTOR: MR. ROBERT A. BRADWAY

 

Management

 

For

 

For

 

1D

 

ELECTION OF DIRECTOR: MR. FRANCOIS DE CARBONNEL

 

Management

 

For

 

For

 

1E

 

ELECTION OF DIRECTOR: DR. VANCE D. COFFMAN

 

Management

 

For

 

For

 

1F

 

ELECTION OF DIRECTOR: MR. ROBERT A. ECKERT

 

Management

 

For

 

For

 

1G

 

ELECTION OF DIRECTOR: MR. GREG C. GARLAND

 

Management

 

For

 

For

 

1H

 

ELECTION OF DIRECTOR: DR. REBECCA M. HENDERSON

 

Management

 

For

 

For

 

1I

 

ELECTION OF DIRECTOR: MR. FRANK C. HERRINGER

 

Management

 

For

 

For

 

1J

 

ELECTION OF DIRECTOR: DR. TYLER JACKS

 

Management

 

For

 

For

 

1K

 

ELECTION OF DIRECTOR: MS. JUDTIH C. PELHAM

 

Management

 

For

 

For

 

1L

 

ELECTION OF DIRECTOR: DR. RONALD D. SUGAR

 

Management

 

For

 

For

 

2

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

3

 

ADVISORY VOTE TO APPROVE OUR EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

 


 

4

 

STOCKHOLDER PROPOSAL #1 (VOTE TABULATION)

 

Shareholder

 

Against

 

For

 

 

ANTISOMA PLC

 

Security

03248123

Meeting Type

Annual

Ticker Symbol

ASM.L

Meeting Date

01-Nov-2013

Record Date

N/A

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO RECEIVE AND ADOPT THE DIRECTOR’S REPORT, THE AUDITED STATEMENT OF ACCOUNTS AND AUDITOR’S REPORT.

 

Management

 

For

 

For

 

2.

 

TO RE-ELECT ROSS HOLLYMAN AS DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

3.

 

TO RE-ELECT PRICEWATERHOUSECOOPERS LLP AS AUDITORS OF THE COMPANY.

 

Management

 

For

 

For

 

4.

 

TO AUTHORISE THE DIRECTORS TO DETERMINE THE AUDITOR’S FEES.

 

Management

 

For

 

For

 

5.

 

TO AUTHORISE THE DIRECTORS TO ALLOT SHARES.

 

Management

 

For

 

For

 

6.

 

TO AUTHORISE THE DISAPPLICATION OF THE STATUTORY PRE-EMPTION RIGHTS.

 

Management

 

For

 

For

 

7.

 

TO CHANGE THE NAME OF THE COMPANY TO SAROSSA CAPITAL PLC.

 

Management

 

For

 

For

 

 

AUXILIUM PHARMACEUTICALS, INC.

 

Security

05334D107

Meeting Type

Annual

Ticker Symbol

AUXL

Meeting Date

21-May-2014

Record Date

01-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROLF A. CLASSON

 

 

 

For

 

For

 

 

 

2

ADRIAN ADAMS

 

 

 

For

 

For

 

 

 

3

PETER C. BRANDT

 

 

 

For

 

For

 

 

 

4

OLIVER S. FETZER, PH.D.

 

 

 

For

 

For

 

 

 

5

PAUL A. FRIEDMAN, M.D.

 

 

 

For

 

For

 

 

 

6

NANCY S. LURKER

 

 

 

For

 

For

 

 

 

7

WILLIAM T. MCKEE

 

 

 

For

 

For

 

2

 

TO RATIFY THE SELECTION BY THE AUDIT AND COMPLIANCE COMMITTEE OF THE COMPANY’S BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

3

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED PURSUANT TO THE COMPENSATION DISCLOSURE RULES OF THE SECURITIES AND EXCHANGE COMMISSION, INCLUDING THE COMPENSATION DISCUSSION AND ANALYSIS, THE COMPENSATION TABLES AND ANY RELATED MATERIALS DISCLOSED IN ... (DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL)

 

Management

 

For

 

For

 

4

 

TO APPROVE AN AMENDMENT AND RESTATEMENT OF THE COMPANY’S CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED COMMON STOCK CAPITAL OF THE COMPANY FROM 120,000,000 TO 150,000,000 SHARES.

 

Management

 

For

 

For

 

5

 

TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE AUXILIUM PHARMACEUTICALS, INC. 2004 EQUITY COMPENSATION PLAN (THE “PLAN”) TO INCREASE THE NUMBER OF SHARES OF COMPANY COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 2,500,000 SHARES FROM 15,800,000 TO 18,300,000 SHARES AND TO INCREASE THE FUNGIBLE SHARE RATIO FROM 1.7 TO 1.88 SHARES.

 

Management

 

For

 

For

 

 

AVANIR PHARMACEUTICALS, INC.

 

Security

05348P401

Meeting Type

Annual

Ticker Symbol

AVNR

Meeting Date

12-Feb-2014

Record Date

16-Dec-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

CORINNE H. NEVINNY

 

 

 

For

 

For

 

 

 

2

DENNIS G. PODLESAK

 

 

 

For

 

For

 

2.

 

RATIFICATION OF SELECTION OF KMJ CORBIN & COMPANY, LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2014.

 

Management

 

For

 

For

 

3.

 

ADVISORY (NON-BINDING) VOTE ON THE COMPANY’S EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

 


 

4.

 

APPROVAL OF 2014 INCENTIVE PLAN.

 

Management

 

For

 

For

 

5.

 

AMEND THE COMPANY’S CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK BY 100,000,000 SHARES.

 

Management

 

For

 

For

 

 

BIOGEN IDEC INC.

 

Security

09062X103

Meeting Type

Annual

Ticker Symbol

BIIB

Meeting Date

12-Jun-2014

Record Date

15-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: CAROLINE D. DORSA

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: STELIOS PAPADOPOULOS

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: GEORGE A. SCANGOS

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: LYNN SCHENK

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: ALEXANDER J. DENNER

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: NANCY L. LEAMING

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: RICHARD C. MULLIGAN

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: ROBERT W. PANGIA

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: BRIAN S. POSNER

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: ERIC K. ROWINSKY

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: STEPHEN A. SHERWIN

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS BIOGEN IDEC INC.’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

3.

 

SAY ON PAY - AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

 

BIOMARIN PHARMACEUTICAL INC.

 

Security

09061G101

Meeting Type

Annual

Ticker Symbol

BMRN

Meeting Date

04-Jun-2014

Record Date

07-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JEAN-JACQUES BIENAIME

 

 

 

For

 

For

 

 

 

2

MICHAEL GREY

 

 

 

For

 

For

 

 

 

3

ELAINE J. HERON

 

 

 

For

 

For

 

 

 

4

PIERRE LAPALME

 

 

 

For

 

For

 

 

 

5

V. BRYAN LAWLIS

 

 

 

For

 

For

 

 

 

6

RICHARD A. MEIER

 

 

 

For

 

For

 

 

 

7

ALAN J. LEWIS

 

 

 

For

 

For

 

 

 

8

WILLIAM D. YOUNG

 

 

 

For

 

For

 

 

 

9

KENNETH M. BATE

 

 

 

For

 

For

 

 

 

10

DENNIS J. SLAMON

 

 

 

For

 

For

 

2

 

TO APPROVE AMENDMENTS TO BIOMARIN’S AMENDED AND RESTATED 2006 EMPLOYEE STOCK PURCHASE PLAN (THE 2006 ESPP) TO INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE 2006 ESPP FROM 2,500,000 TO 3,500,000 AND TO EXTEND THE TERM OF THE 2006 ESPP TO MAY 2, 2018.

 

Management

 

For

 

For

 

 


 

3

 

TO VOTE ON AN ADVISORY BASIS TO APPROVE THE COMPENSATION OF BIOMARIN’S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN ITS PROXY STATEMENT.

 

Management

 

For

 

For

 

4

 

TO RATIFY THE SELECTION OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR BIOMARIN FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 

BLUEBIRD BIO INC.

 

Security

09609G100

Meeting Type

Annual

Ticker Symbol

BLUE

Meeting Date

11-Jun-2014

Record Date

21-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

STEVEN GILLIS

 

 

 

For

 

For

 

 

 

2

NICK LESCHLY

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 

CARDIOKINETIX, INC.

 

Security

N/A

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

Meeting Date

15-Oct-2013

Record Date

N/A

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

CERTIFICATE OF AMENDMENT TO SIXTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

2.

 

ELECTION OF DIRECTORS.

 

Management

 

For

 

For

 

3.

 

GENERAL AUTHORIZING RESOLUTION.

 

Management

 

For

 

For

 

 

CELGENE CORPORATION

 

Security

151020104

Meeting Type

Annual

Ticker Symbol

CELG

Meeting Date

18-Jun-2014

Record Date

21-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT J. HUGIN

 

 

 

For

 

For

 

 

 

2

R.W. BARKER, D. PHIL.

 

 

 

For

 

For

 

 

 

3

MICHAEL D. CASEY

 

 

 

For

 

For

 

 

 

4

CARRIE S. COX

 

 

 

For

 

For

 

 

 

5

RODMAN L. DRAKE

 

 

 

For

 

For

 

 

 

6

M.A. FRIEDMAN, M.D.

 

 

 

For

 

For

 

 

 

7

GILLA KAPLAN, PH.D.

 

 

 

For

 

For

 

 

 

8

JAMES J. LOUGHLIN

 

 

 

For

 

For

 

 

 

9

ERNEST MARIO, PH.D.

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

3.

 

AMENDMENT OF THE COMPANY’S CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF COMMON STOCK AND TO EFFECT A STOCK SPLIT.

 

Management

 

For

 

For

 

4.

 

APPROVAL OF AN AMENDMENT OF THE COMPANY’S 2008 STOCK INCENTIVE PLAN.

 

Management

 

For

 

For

 

5.

 

APPROVAL, BY NON-BINDING VOTE, OF EXECUTIVE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

6.

 

STOCKHOLDER PROPOSAL DESCRIBED IN MORE DETAIL IN THE PROXY STATEMENT.

 

Shareholder

 

For

 

Against

 

 

CELLADON CORPORATION

 

Security

US15117E1073

Meeting Type

Annual

Ticker Symbol

CLDN

Meeting Date

20-May-2014

Record Date

17-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

ELECTION OF ALL CLASS I DIRECTIORS .

 

Management

 

For

 

For

 

2.

 

RATIFY ERNST & YOUNG AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 

CELLADON CORPORATION

 

Security

N/A

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

Meeting Date

9-Oct-2013

Record Date

N/A

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

REVERSE SPLIT OF THE COMPANY’S COMMON STOCK.

 

Management

 

For

 

For

 

2.

 

GENERAL AUTHORIZING RESOLUTION.

 

Management

 

For

 

For

 

 

CLOVIS ONCOLOGY INC.

 

Security

189464100

Meeting Type

Annual

Ticker Symbol

CLVS

Meeting Date

12-Jun-2014

Record Date

14-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

KEITH FLAHERTY, M.D.

 

 

 

For

 

For

 

 


 

 

 

2

GINGER GRAHAM

 

 

 

For

 

For

 

 

 

3

EDWARD J. MCKINLEY

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 

CORNERSTONE THERAPEUTICS INC

 

Security

21924P103

Meeting Type

Annual

Ticker Symbol

CRTX

Meeting Date

31-Oct-2013

Record Date

12-Sep-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

CRAIG A. COLLARD

 

 

 

For

 

For

 

 

 

2

CHRISTOPHER CODEANNE

 

 

 

For

 

For

 

 

 

3

MICHAEL ENRIGHT

 

 

 

For

 

For

 

 

 

4

ANTON GIORGIO FAILLA

 

 

 

For

 

For

 

 

 

5

JAMES HARPER

 

 

 

For

 

For

 

 

 

6

MICHAEL HEFFERNAN

 

 

 

For

 

For

 

 

 

7

LAURA SHAWVER

 

 

 

For

 

For

 

 

 

8

ROBERT M. STEPHAN

 

 

 

For

 

For

 

 

 

9

MARCO VECCHIA

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE SELECTION BY THE AUDIT COMMITTEE OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2013.

 

Management

 

For

 

For

 

 

CUBIST PHARMACEUTICALS, INC.

 

Security

229678107

Meeting Type

Annual

Ticker Symbol

CBST

Meeting Date

03-Jun-2014

Record Date

08-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: MICHAEL BONNEY

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: JANE HENNEY, M.D.

 

Management

 

For

 

For

 

1.3

 

ELECTION OF DIRECTOR: LEON MOULDER, JR.

 

Management

 

For

 

For

 

2.

 

ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

APPROVAL OF THE AMENDMENT TO OUR RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 150,000,000 TO 300,000,000.

 

Management

 

For

 

For

 

4.

 

APPROVAL OF OUR 2014 EMPLOYEE STOCK PURCHASE PLAN.

 

Management

 

For

 

For

 

5.

 

APPROVAL OF OUR 2014 OMNIBUS INCENTIVE PLAN.

 

Management

 

For

 

For

 

6.

 

RATIFICATION OF OUR SELECTION OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 

ENDO HEALTH SOLUTIONS INC.

 

Security

29264F205

Meeting Type

Special

Ticker Symbol

ENDP

Meeting Date

26-Feb-2014

Record Date

22-Jan-2014

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO APPROVE AND ADOPT THE ARRANGEMENT AGREEMENT AND THE TRANSACTIONS CONTEMPLATED THEREBY (INCLUDING THE MERGER).

 

Management

 

For

 

For

 

2.

 

TO APPROVE, ON A NON-BINDING ADVISORY BASIS, CERTAIN COMPENSATORY ARRANGEMENTS BETWEEN ENDO AND ITS NAMED EXECUTIVE OFFICERS RELATING TO THE MERGER CONTEMPLATED BY THE ARRANGEMENT AGREEMENT.

 

Management

 

For

 

For

 

3.

 

TO APPROVE THE CREATION OF “DISTRIBUTABLE RESERVES” OF NEW ENDO, WHICH ARE REQUIRED UNDER IRISH LAW IN ORDER TO ALLOW NEW ENDO TO MAKE DISTRIBUTIONS AND PAY DIVIDENDS AND TO PURCHASE OR REDEEM SHARES IN THE FUTURE BY REDUCING SOME OR ALL OF THE SHARE PREMIUM OF NEW ENDO.

 

Management

 

For

 

For

 

4.

 

TO APPROVE ANY MOTION TO ADJOURN THE SPECIAL MEETING OR ANY ADJOURNMENT THEREOF, IF NECESSARY, (I) TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF THE PROPOSAL AT THE TIME OF THE SPECIAL MEETING TO ADOPT THE ARRANGEMENT AGREEMENT AND TRANSACTIONS CONTEMPLATED THEREBY... (DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL).

 

Management

 

For

 

For

 

 

ENDO INTERNATIONAL PLC

 

Security

G30401106

Meeting Type

Annual

Ticker Symbol

ENDP

Meeting Date

10-Jun-2014

Record Date

15-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: ROGER H. KIMMEL

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: RAJIV DE SILVA

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: JOHN J. DELUCCA

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: ARTHUR J. HIGGINS

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: NANCY J. HUTSON, PH.D.

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: MICHAEL HYATT

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: WILLIAM P. MONTAGUE

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: JILL D. SMITH

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: WILLIAM F. SPENGLER

 

Management

 

For

 

For

 

2.

 

TO APPROVE THE APPOINTMENT OF DELOITTE & TOUCHE AS THE COMPANY’S INDEPENDENT AUDITORS FOR THE YEAR ENDING DECEMBER 31, 2014 AND TO AUTHORIZE THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS TO DETERMINE THE AUDITORS’ REMUNERATION.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, BY ADVISORY VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

4.

 

TO APPROVE THE AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN.

 

Management

 

For

 

For

 

 

GILEAD SCIENCES, INC.

 

Security

375558103

Meeting Type

Annual

Ticker Symbol

GILD

Meeting Date

07-May-2014

Record Date

12-Mar-2014

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: JOHN F. COGAN

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: ETIENNE F. DAVIGNON

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: CARLA A. HILLS

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: KEVIN E. LOFTON

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: JOHN W. MADIGAN

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: JOHN C. MARTIN

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: NICHOLAS G. MOORE

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: RICHARD J. WHITLEY

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: GAYLE E. WILSON

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: PER WOLD-OLSEN

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GILEAD FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

3.

 

TO VOTE ON A PROPOSED AMENDMENT TO GILEAD’S RESTATED CERTIFICATE OF INCORPORATION TO DESIGNATE DELAWARE CHANCERY COURT AS THE EXCLUSIVE FORUM FOR CERTAIN LEGAL ACTIONS.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS PRESENTED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

5.

 

TO VOTE ON A STOCKHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT THE BOARD ADOPT A POLICY THAT THE CHAIRMAN OF THE BOARD OF DIRECTORS BE AN INDEPENDENT DIRECTOR.

 

Shareholder

 

Against

 

For

 

6.

 

TO VOTE ON A STOCKHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT THE BOARD TAKE STEPS TO PERMIT STOCKHOLDER ACTION BY WRITTEN CONSENT.

 

Shareholder

 

Against

 

For

 

7.

 

TO VOTE ON A STOCKHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT THE BOARD ADOPT A POLICY THAT INCENTIVE COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER INCLUDE NON-FINANCIAL MEASURES BASED ON PATIENT ACCESS TO GILEAD’S MEDICINES.

 

Shareholder

 

Against

 

For

 

 

HERON THERAPEUTICS INC.

 

Security

427746102

Meeting Type

Annual

Ticker Symbol

HRTX

Meeting Date

27-May-2014

Record Date

28-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

KEVIN C. TANG

 

 

 

For

 

For

 

 

 

2

STEPHEN R. DAVIS

 

 

 

For

 

For

 

 

 

3

BARRY D. QUART, PHARM D

 

 

 

For

 

For

 

 

 

4

ROBERT H. ROSEN

 

 

 

For

 

For

 

 

 

5

CRAIG A. JOHNSON

 

 

 

For

 

For

 

 

 

6

KIMBERLY J. MANHARD

 

 

 

For

 

For

 

 

 

7

JOHN W. POYHONEN

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF OUM & CO. LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 


 

3.

 

TO CONDUCT AN ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS DURING FISCAL YEAR 2013.

 

Management

 

For

 

For

 

4.

 

TO AMEND THE COMPANY’S AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN TO INCREASE THE SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE THEREUNDER BY 1,750,000 SHARES.

 

Management

 

For

 

For

 

5.

 

TO AMEND THE COMPANY’S 1997 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED, TO INCREASE THE SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE THEREUNDER BY 25,000 SHARES.

 

Management

 

For

 

For

 

 

HOLOGIC, INC.

 

Security

436440101

Meeting Type

Annual

Ticker Symbol

HOLX

Meeting Date

04-Mar-2014

Record Date

10-Jan-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JONATHAN CHRISTODORO

 

 

 

For

 

For

 

 

 

2

SALLY W. CRAWFORD

 

 

 

For

 

For

 

 

 

3

SCOTT T. GARRETT

 

 

 

For

 

For

 

 

 

4

DAVID R. LAVANCE, JR.

 

 

 

For

 

For

 

 

 

5

NANCY L. LEAMING

 

 

 

For

 

For

 

 

 

6

LAWRENCE M. LEVY

 

 

 

For

 

For

 

 

 

7

STEPHEN P. MACMILLAN

 

 

 

For

 

For

 

 

 

8

SAMUEL MERKSAMER

 

 

 

For

 

For

 

 

 

9

CHRISTIANA STAMOULIS

 

 

 

For

 

For

 

 

 

10

ELAINE S. ULLIAN

 

 

 

For

 

For

 

 

 

11

WAYNE WILSON

 

 

 

For

 

For

 

2.

 

A NON-BINDING ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

3.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL 2014.

 

Management

 

For

 

For

 

 

IDEXX LABORATORIES, INC.

 

Security

45168D104

Meeting Type

Annual

Ticker Symbol

IDXX

Meeting Date

07-May-2014

Record Date

10-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

THOMAS CRAIG

 

 

 

For

 

For

 

 

 

2

R.M. HENDERSON, PHD

 

 

 

For

 

For

 

 

 

3

S.V. VANDEBROEK, PHD

 

 

 

For

 

For

 

2.

 

ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. TO APPROVE A NONBINDING ADVISORY RESOLUTION ON THE COMPANY’S EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

3.

 

ADOPTION OF THE IDEXX LABORATORIES, INC. 2014 INCENTIVE COMPENSATION PLAN. TO APPROVE THE ADOPTION OF THE COMPANY’S 2014 INCENTIVE COMPENSATION PLAN.

 

Management

 

For

 

For

 

 


 

4.

 

RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR.

 

Management

 

For

 

For

 

 

ILLUMINA, INC.

 

Security

452327109

Meeting Type

Annual

Ticker Symbol

ILMN

Meeting Date

28-May-2014

Record Date

01-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

DANIEL M. BRADBURY*

 

 

 

For

 

For

 

 

 

2

ROBERT S. EPSTEIN, MD*

 

 

 

For

 

For

 

 

 

3

ROY A. WHITFIELD*

 

 

 

For

 

For

 

 

 

4

FRANCIS A. DESOUZA#

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 28, 2014

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT

 

Management

 

For

 

For

 

4.

 

TO APPROVE AN AMENDMENT TO THE ILLUMINA, INC. BYLAWS, ESTABLISHING DELAWARE AS THE EXCLUSIVE FORUM FOR ADJUDICATION OF CERTAIN DISPUTES

 

Management

 

For

 

For

 

 

ILLUMINOSS MEDICAL, INC.

 

Security

N/A

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

Meeting Date

13-Jun-2014

Record Date

N/A

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

2.

 

INTERESTED DIRECTOR RESOLUTIONS.

 

Management

 

For

 

For

 

3.

 

WAIVER OF PREEMPTIVE RIGHTS.

 

Management

 

For

 

For

 

4.

 

GENERAL AUTHORIZING RESOLUTION.

 

Management

 

For

 

For

 

 

IMPAX LABORATORIES, INC.

 

Security

45256B101

Meeting Type

Annual

Ticker Symbol

IPXL

Meeting Date

13-May-2014

Record Date

04-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

LESLIE Z. BENET, PH.D.

 

 

 

For

 

For

 

 

 

2

ROBERT L. BURR

 

 

 

For

 

For

 

 

 

3

ALLEN CHAO, PH.D.

 

 

 

For

 

For

 

 

 

4

NIGEL TEN FLEMING, PHD

 

 

 

For

 

For

 

 

 

5

LARRY HSU, PH.D.

 

 

 

For

 

For

 

 

 

6

MICHAEL MARKBREITER

 

 

 

For

 

For

 

 

 

7

MARY K. PENDERGAST, JD

 

 

 

For

 

For

 

 

 

8

PETER R. TERRERI

 

 

 

For

 

For

 

2.

 

TO APPROVE, BY NON-BINDING VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

3.

 

RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 

INCYTE CORPORATION

 

Security

45337C102

Meeting Type

Annual

Ticker Symbol

INCY

Meeting Date

28-May-2014

Record Date

10-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

RICHARD U. DE SCHUTTER

 

 

 

For

 

For

 

 


 

 

 

2

BARRY M. ARIKO

 

 

 

For

 

For

 

 

 

3

JULIAN C. BAKER

 

 

 

For

 

For

 

 

 

4

PAUL A. BROOKE

 

 

 

For

 

For

 

 

 

5

WENDY L. DIXON

 

 

 

For

 

For

 

 

 

6

PAUL A. FRIEDMAN

 

 

 

For

 

For

 

 

 

7

HERVE HOPPENOT

 

 

 

For

 

For

 

2.

 

TO APPROVE THE AMENDMENTS TO THE COMPANY’S AMENDED AND RESTATED 2010 STOCK INCENTIVE PLAN.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

4.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2014.

 

Management

 

For

 

For

 

 

INFINITY PHARMACEUTICALS, INC.

 

Security

45665G303

Meeting Type

Annual

Ticker Symbol

INFI

Meeting Date

17-Jun-2014

Record Date

21-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: JOSE BASELGA, MD, PHD

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: JEFFREY BERKOWITZ, JD

 

Management

 

For

 

For

 

1.3

 

ELECTION OF DIRECTOR: ANTHONY B. EVNIN, PHD

 

Management

 

For

 

For

 

1.4

 

ELECTION OF DIRECTOR: GWEN A. FYFE, MD

 

Management

 

For

 

For

 

1.5

 

ELECTION OF DIRECTOR: ERIC S. LANDER, PHD

 

Management

 

For

 

For

 

1.6

 

ELECTION OF DIRECTOR: ADELENE Q. PERKINS

 

Management

 

For

 

For

 

1.7

 

ELECTION OF DIRECTOR: NORMAN C. SELBY

 

Management

 

For

 

For

 

1.8

 

ELECTION OF DIRECTOR: IAN F. SMITH

 

Management

 

For

 

For

 

1.9

 

ELECTION OF DIRECTOR: MICHAEL C. VENUTI, PHD

 

Management

 

For

 

For

 

2

 

TO APPROVE ON AN ADVISORY BASIS THE EXECUTIVE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE 2014 FISCAL YEAR.

 

Management

 

For

 

For

 

 

INSIGHTRA MEDICAL, INC.

 

Security

N/A

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

Meeting Date

17-Apr-2014

Record Date

N/A

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

AMENDMENT OF ARTICLES OF INCORPORATION.

 

Management

 

For

 

For

 

2.

 

AMENDMENT TO OPTION PLAN.

 

Management

 

For

 

For

 

3.

 

OMNIBUS RESOLUTION.

 

Management

 

For

 

For

 

 

INTELLIPHARMACEUTICS INTERNATIONAL INC.

 

Security

458173101

Meeting Type

Special

Ticker Symbol

IPCI

Meeting Date

27-Mar-2014

Record Date

N/A

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

TO ELECT DIRECTOR DR. ISA ODIDI AS DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

1B.

 

TO ELECT DIRECTOR DR. AMINA ODIDI AS DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

1C.

 

TO ELECT DIRECTOR JOHN ALLPORT AS DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

1D.

 

TO ELECT DIRECTOR BAHADUR MADHANI AS DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

1E.

 

TO ELECT DIRECTOR KENNETH KEIRSTEAD AS DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

1F.

 

TO ELECT DIRECTOR DR. ELDON R. SMITH AS DIRECTOR OF THE COMPANY.

 

Management

 

For

 

For

 

2.

 

ON THE REAPPOINTMENT OF DELOITTE LLP, CHARTERED ACCOUNTANTS, AS THE AUDITOR OF THE COMPANY AND TO AUTHORIZE THE DIRECTORS TO FIX THE AUDITOR’S REMUNERATION.

 

Management

 

For

 

For

 

3.

 

THE RESOLUTION APPROVING THE TWO YEAR EXTENSION OF THE PERFORMANCE-BASED STOCK OPTIONS GRANTED TO CERTAIN DIRECTORS AND OFFICERS AS MORE PARTICULARLY DESCRIBED IN THE MANAGEMENT PROXY CIRCULAR FOR THE MEETING.

 

Management

 

For

 

For

 

 

IRONWOOD PHARMACEUTICALS, INC.

 

Security

46333X108

Meeting Type

Annual

Ticker Symbol

IRWD

Meeting Date

03-Jun-2014

Record Date

10-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

BRYAN E. ROBERTS

 

 

 

For

 

For

 

 

 

2

JULIE H. MCHUGH

 

 

 

For

 

For

 

 

 

3

PETER M. HECHT

 

 

 

For

 

For

 

2.

 

APPROVAL, BY NON-BINDING ADVISORY VOTE, OF THE COMPENSATION PAID TO THE NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2014.

 

Management

 

For

 

For

 

 


 

MEI PHARMA, INC.

 

Security

55279B202

Meeting Type

Annual

Ticker Symbol

MEIP

Meeting Date

05-Dec-2013

Record Date

11-Oct-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

WILLIAM D. RUECKERT

 

 

 

For

 

For

 

 

 

2

CHRISTINE A. WHITE M.D.

 

 

 

For

 

For

 

 

 

3

THOMAS C REYNOLDS M.D.

 

 

 

For

 

For

 

2.

 

RATIFICATION OF APPOINTMENT OF BDO USA, LLP AS MEI PHARMA, INC.’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2014.

 

Management

 

For

 

For

 

3.

 

APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF MEI PHARMA, INC.’S NAMED EXECUTIVE OFFICERS (“SAY- ON-PAY VOTE”).

 

Management

 

Against

 

Against

 

 

MERRIMACK PHARMACEUTICALS, INC.

 

Security

590328100

Meeting Type

Annual

Ticker Symbol

MACK

Meeting Date

13-May-2014

Record Date

18-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT J. MULROY

 

 

 

For

 

For

 

 

 

2

GARY L. CROCKER

 

 

 

For

 

For

 

 

 

3

JAMES VAN B. DRESSER

 

 

 

For

 

For

 

 

 

4

GORDON J. FEHR

 

 

 

For

 

For

 

 

 

5

JOHN MENDELSOHN, MD

 

 

 

For

 

For

 

 

 

6

SARAH E. NASH

 

 

 

For

 

For

 

 

 

7

MICHAEL E. PORTER, PHD

 

 

 

For

 

For

 

 

 

8

JAMES H. QUIGLEY

 

 

 

For

 

For

 

 

 

9

ANTHONY J. SINSKEY, SCD

 

 

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS MERRIMACK PHARMACEUTICALS, INC.’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 

MOMENTA PHARMACEUTICALS, INC.

 

Security

60877T100

Meeting Type

Annual

Ticker Symbol

MNTA

Meeting Date

11-Jun-2014

Record Date

14-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

BRUCE L. DOWNEY

 

 

 

For

 

For

 

 

 

2

MARSHA H. FANUCCI

 

 

 

For

 

For

 

 

 

3

PETER BARTON HUTT

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON AN ADVISORY (NON- BINDING) BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

4.

 

TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE EMPLOYEE STOCK PURCHASE PLAN.

 

Management

 

For

 

For

 

 


 

5.

 

TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE 2013 INCENTIVE AWARD PLAN.

 

Management

 

For

 

For

 

 

MYLAN INC.

 

Security

628530107

Meeting Type

Annual

Ticker Symbol

MYL

Meeting Date

11-Apr-2014

Record Date

20-Feb-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: HEATHER BRESCH

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: WENDY CAMERON

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: HON. ROBERT J. CINDRICH

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: ROBERT J. COURY

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: JOELLEN LYONS DILLON

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: NEIL DIMICK, C.P.A.

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: MELINA HIGGINS

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: DOUGLAS J. LEECH, C.P.A.

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: RAJIV MALIK

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: JOSEPH C. MAROON, M.D.

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: MARK W. PARRISH

 

Management

 

For

 

For

 

1L.

 

ELECTION OF DIRECTOR: RODNEY L. PIATT, C.P.A.

 

Management

 

For

 

For

 

1M.

 

ELECTION OF DIRECTOR: RANDALL L. (PETE) VANDERVEEN, PH.D., R.PH

 

Management

 

For

 

For

 

2.

 

RATIFY THE SELECTION OF DELOITTE & TOUCHE LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2014

 

Management

 

For

 

For

 

3.

 

APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS OF THE COMPANY

 

Management

 

For

 

For

 

4.

 

CONSIDER A SHAREHOLDER PROPOSAL TO ADOPT A POLICY THAT THE CHAIRMAN OF THE BOARD OF DIRECTORS BE AN INDEPENDENT DIRECTOR

 

Shareholder

 

Against

 

For

 

 

NEUROCRINE BIOSCIENCES, INC.

 

Security

64125C109

Meeting Type

Annual

Ticker Symbol

NBIX

Meeting Date

22-May-2014

Record Date

01-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

KEVIN C. GORMAN

 

 

 

For

 

For

 

 

 

2

GARY A. LYONS

 

 

 

For

 

For

 

 

 

3

WILLIAM H. RASTETTER

 

 

 

For

 

For

 

2.

 

ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO THE COMPANY’S 2011 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE THEREUNDER FROM 7,000,000 TO 8,500,000.

 

Management

 

For

 

For

 

4.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 

NEUROVANCE, INC.

 

Security

N/A

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

Meeting Date

9-Oct-2013

Record Date

N/A

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

2.

 

DETERMINATION OF MILESTONE SATISFACTION.

 

Management

 

For

 

For

 

 


 

NPS PHARMACEUTICALS, INC.

 

Security

62936P103

Meeting Type

Annual

Ticker Symbol

NPSP

Meeting Date

06-May-2014

Record Date

21-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: MICHAEL W. BONNEY

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: COLIN BROOM

 

Management

 

For

 

For

 

1.3

 

ELECTION OF DIRECTOR: GEORGES GEMAYEL

 

Management

 

For

 

For

 

1.4

 

ELECTION OF DIRECTOR: PEDRO GRANADILLO

 

Management

 

For

 

For

 

1.5

 

ELECTION OF DIRECTOR: JAMES G. GRONINGER

 

Management

 

For

 

For

 

1.6

 

ELECTION OF DIRECTOR: FRANCOIS NADER

 

Management

 

For

 

For

 

1.7

 

ELECTION OF DIRECTOR: RACHEL R. SELISKER

 

Management

 

For

 

For

 

1.8

 

ELECTION OF DIRECTOR: PETER G. TOMBROS

 

Management

 

For

 

For

 

2.

 

TO APPROVE THE ADOPTION OF OUR 2014 OMNIBUS EQUITY COMPENSATION PLAN AND AUTHORIZE THE RESERVATION OF 7,000,000 SHARES FOR ISSUANCE UNDER SUCH PLAN.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

4.

 

TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 

ONCOGENEX PHARMACEUTICALS, INC

 

Security

68230A106

Meeting Type

Annual

Ticker Symbol

OGXI

Meeting Date

29-May-2014

Record Date

08-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

SCOTT CORMACK

 

 

 

For

 

For

 

 

 

2

NEIL CLENDENINN

 

 

 

For

 

For

 

 

 

3

JACK GOLDSTEIN

 

 

 

For

 

For

 

 

 

4

MARTIN MATTINGLY

 

 

 

For

 

For

 

 

 

5

STEWART PARKER

 

 

 

For

 

For

 

 

 

6

DAVID SMITH

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO OUR 2010 PERFORMANCE INCENTIVE PLAN THAT WILL INCREASE THE TOTAL SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE UNDER THE 2010 PERFORMANCE INCENTIVE PLAN FROM 2,050,000 TO 2,800,000.

 

Management

 

Against

 

Against

 

4.

 

TO APPROVE, BY A NON-BINDING ADVISORY VOTE, A RESOLUTION APPROVING THE COMPENSATION PAID BY US TO OUR NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

 

PERKINELMER, INC.

 

Security

714046109

Meeting Type

Annual

Ticker Symbol

PKI

Meeting Date

22-Apr-2014

Record Date

24-Feb-2014

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: PETER BARRETT

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: ROBERT F. FRIEL

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: NICHOLAS A. LOPARDO

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: ALEXIS P. MICHAS

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: JAMES C. MULLEN

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: VICKI L. SATO, PH.D.

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: KENTON J. SICCHITANO

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: PATRICK J. SULLIVAN

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF DELOITTE & TOUCHE LLP AS PERKINELMER’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR

 

Management

 

For

 

For

 

3.

 

TO APPROVE, BY NON-BINDING ADVISORY VOTE, OUR EXECUTIVE COMPENSATION

 

Management

 

For

 

For

 

4.

 

TO RE-APPROVE THE PERKINELMER, INC. 2009 INCENTIVE PLAN

 

Management

 

For

 

For

 

 

PERRIGO COMPANY

 

Security

714290103

Meeting Type

Special

Ticker Symbol

PRGO

Meeting Date

18-Nov-2013

Record Date

15-Oct-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

ADOPTING THE TRANSACTION AGREEMENT, DATED JULY 28, 2013, BETWEEN AND AMONG ELAN CORPORATION, PLC (“ELAN”), PERRIGO COMPANY (“PERRIGO”), LEOPARD COMPANY, HABSONT LIMITED AND PERRIGO COMPANY LIMITED (F/K/A BLISFONT LIMITED) (“NEW PERRIGO”) (THE ‘‘TRANSACTION AGREEMENT”) AND APPROVING THE MERGER.

 

Management

 

For

 

For

 

2.

 

APPROVING THE CREATION OF DISTRIBUTABLE RESERVES, BY REDUCING SOME OR ALL OF THE SHARE PREMIUM OF NEW PERRIGO RESULTING FROM THE ISSUANCE OF NEW PERRIGO ORDINARY SHARES PURSUANT TO THE SCHEME OF ARRANGEMENT BY WHICH NEW PERRIGO WILL ACQUIRE ELAN.

 

Management

 

For

 

For

 

3.

 

CONSIDERING AND, ON A NON-BINDING ADVISORY BASIS, VOTING UPON SPECIFIED COMPENSATORY ARRANGEMENTS BETWEEN PERRIGO AND ITS NAMED EXECUTIVE OFFICERS RELATING TO THE TRANSACTION AGREEMENT.

 

Management

 

For

 

For

 

4.

 

RE-APPROVING THE PERFORMANCE GOALS INCLUDED IN THE PERRIGO COMPANY ANNUAL INCENTIVE PLAN.

 

Management

 

For

 

For

 

5.

 

APPROVING THE AMENDMENT AND RESTATEMENT OF THE PERRIGO COMPANY 2008 LONG TERM INCENTIVE PLAN.

 

Management

 

For

 

For

 

6.

 

APPROVING ANY MOTION TO ADJOURN THE PERRIGO SPECIAL MEETING, OR ANY ADJOURNMENTS THEREOF, TO ANOTHER TIME OR PLACE IF NECESSARY OR APPROPRIATE, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

 

PHARMACYCLICS, INC.

 

Security

716933106

Meeting Type

Annual

Ticker Symbol

PCYC

Meeting Date

08-May-2014

Record Date

31-Mar-2014

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT F. BOOTH, PH.D.

 

 

 

For

 

For

 

 

 

2

KENNETH A. CLARK

 

 

 

For

 

For

 

 

 

3

ROBERT W. DUGGAN

 

 

 

For

 

For

 

 

 

4

ERIC H. HALVORSON

 

 

 

For

 

For

 

 

 

5

MINESH P. MEHTA, M.D.

 

 

 

For

 

For

 

 

 

6

DAVID D. SMITH, PH.D.

 

 

 

For

 

For

 

 

 

7

RICHARD VAN DEN BROEK

 

 

 

For

 

For

 

2

 

TO APPROVE THE COMPANY’S 2014 EQUITY INCENTIVE AWARD PLAN.

 

Management

 

For

 

For

 

3

 

TO APPROVE AN ADVISORY RESOLUTION REGARDING THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

4

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 

PTC THERAPEUTICS, INC.

 

Security

69366J200

Meeting Type

Annual

Ticker Symbol

PTCT

Meeting Date

10-Jun-2014

Record Date

15-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

STUART W. PELTZ, PH.D.

 

 

 

For

 

For

 

 

 

2

J.B. ZELDIS, MD, PHD

 

 

 

For

 

For

 

 

 

3

RONALD C. RENAUD, JR.

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 

PUMA BIOTECHNOLOGY, INC.

 

Security

74587V107

Meeting Type

Annual

Ticker Symbol

PBYI

Meeting Date

10-Jun-2014

Record Date

17-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ALAN H. AUERBACH

 

 

 

For

 

For

 

 

 

2

THOMAS R. MALLEY

 

 

 

For

 

For

 

 

 

3

JAY M. MOYES

 

 

 

For

 

For

 

 

 

4

TROY E. WILSON

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE SELECTION OF PKF CERTIFIED PUBLIC ACCOUNTANTS, A PROFESSIONAL CORPORATION, AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF PUMA BIOTECHNOLOGY, INC. FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

3.

 

APPROVAL OF AN AMENDMENT TO THE PUMA BIOTECHNOLOGY, INC. 2011 INCENTIVE AWARD PLAN.

 

Management

 

For

 

For

 

 

REGENERON PHARMACEUTICALS, INC.

 

Security

75886F107

Meeting Type

Annual

Ticker Symbol

REGN

Meeting Date

13-Jun-2014

Record Date

17-Apr-2014

 

 

 


 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ALFRED G. GILMAN

 

 

 

For

 

For

 

 

 

2

JOSEPH L. GOLDSTEIN

 

 

 

For

 

For

 

 

 

3

ROBERT A. INGRAM

 

 

 

For

 

For

 

 

 

4

CHRISTINE A. POON

 

 

 

For

 

For

 

 

 

5

P. ROY VAGELOS

 

 

 

For

 

For

 

2.

 

PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

3.

 

PROPOSAL TO APPROVE, ON AN ADVISORY BASIS, EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

4.

 

PROPOSAL TO APPROVE THE REGENERON PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLAN.

 

Management

 

For

 

For

 

 

SAGENT PHARMACEUTICALS, INC

 

Security

786692103

Meeting Type

Annual

Ticker Symbol

SGNT

Meeting Date

12-Jun-2014

Record Date

16-Apr-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO ADOPT AND APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO DECLASSIFY THE BOARD OF DIRECTORS AND PROVIDE FOR THE ANNUAL ELECTION OF ALL DIRECTORS, COMMENCING WITH THE 2016 ANNUAL MEETING OF STOCKHOLDERS

 

Management

 

For

 

For

 

2.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT FLANAGAN

 

 

 

For

 

For

 

 

 

2

FRANK KUNG

 

 

 

For

 

For

 

3.

 

TO RATIFY THE RETENTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014

 

Management

 

For

 

For

 

4.

 

TO HOLD AN ADVISORY VOTE TO APPROVE THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS

 

Management

 

For

 

For

 

 

SANGAMO BIOSCIENCES, INC.

 

Security

800677106

Meeting Type

Annual

Ticker Symbol

SGMO

Meeting Date

21-Apr-2014

Record Date

06-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

EDWARD O. LANPHIER II

 

 

 

For

 

For

 

 

 

2

PAUL B. CLEVELAND

 

 

 

For

 

For

 

 

 

3

S.G. DILLY, MBBS, PH.D.

 

 

 

For

 

For

 

 

 

4

JOHN W. LARSON

 

 

 

For

 

For

 

 

 

5

STEVEN J. MENTO, PH.D.

 

 

 

For

 

For

 

 

 

6

SAIRA RAMASASTRY

 

 

 

For

 

For

 

 

 

7

WILLIAM R. RINGO

 

 

 

For

 

For

 

2.

 

SAY ON PAY - AN ADVISORY VOTE ON THE APPROVAL OF EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 80,000,000 TO 160,000,000 SHARES.

 

Management

 

For

 

For

 

 


 

4.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 

SHIRE PLC

 

Security

82481R106

Meeting Type

Annual

Ticker Symbol

SHPG

Meeting Date

29-Apr-2014

Record Date

18-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO RECEIVE THE COMPANY’S ANNUAL REPORT AND ACCOUNTS FOR THE YEAR ENDED DECEMBER 31, 2013.

 

Management

 

For

 

For

 

2.

 

TO APPROVE THE DIRECTORS’ REMUNERATION REPORT, EXCLUDING THE DIRECTORS’ REMUNERATION POLICY, SET OUT ON PAGES 64 TO 90 OF THE 2013 ANNUAL REPORT AND ACCOUNTS, FOR THE YEAR ENDED DECEMBER 31, 2013.

 

Management

 

For

 

For

 

3.

 

TO APPROVE THE DIRECTORS’ REMUNERATION POLICY, SET OUT ON PAGES 66 TO 74 OF THE DIRECTORS’ REMUNERATION REPORT, WHICH TAKES EFFECT ON JANUARY 1, 2015.

 

Management

 

For

 

For

 

4.

 

TO ELECT DOMINIC BLAKEMORE AS A DIRECTOR.

 

Management

 

For

 

For

 

5.

 

TO RE-ELECT WILLIAM BURNS AS A DIRECTOR.

 

Management

 

For

 

For

 

6.

 

TO RE-ELECT DR. STEVEN GILLIS AS A DIRECTOR.

 

Management

 

For

 

For

 

7.

 

TO RE-ELECT DR. DAVID GINSBURG AS A DIRECTOR.

 

Management

 

For

 

For

 

8.

 

TO RE-ELECT DAVID KAPPLER AS A DIRECTOR.

 

Management

 

For

 

For

 

9.

 

TO RE-ELECT SUSAN KILSBY AS A DIRECTOR.

 

Management

 

For

 

For

 

10.

 

TO RE-ELECT ANNE MINTO AS A DIRECTOR.

 

Management

 

For

 

For

 

11.

 

TO RE-ELECT DR. FLEMMING ORNSKOV AS A DIRECTOR.

 

Management

 

For

 

For

 

12.

 

TO RE-ELECT DAVID STOUT AS A DIRECTOR.

 

Management

 

For

 

For

 

13.

 

TO RE-APPOINT DELOITTE LLP AS THE COMPANY’S AUDITOR UNTIL THE CONCLUSION OF THE NEXT ANNUAL GENERAL MEETING OF THE COMPANY.

 

Management

 

For

 

For

 

14.

 

TO AUTHORIZE THE AUDIT, COMPLIANCE & RISK COMMITTEE TO DETERMINE THE REMUNERATION OF THE AUDITOR.

 

Management

 

For

 

For

 

15.

 

THAT SANCTION BE AND IS HEREBY GIVEN TO THE DIRECTORS OF THE COMPANY PERMITTING THE AGGREGATE PRINCIPAL AMOUNT AT ANY TIME OUTSTANDING IN RESPECT OF MONEYS BORROWED (AS DEFINED IN THE COMPANY’S ARTICLES OF ASSOCIATION (THE “ARTICLES”)) BY THE GROUP (AS DEFINED IN THE ARTICLES) TO EXCEED THE LIMIT IMPOSED BY ARTICLE 107 OF THE ARTICLES PROVIDED THAT THE SANCTION HEREBY GIVEN SHALL NOT EXTEND TO PERMIT THE AGGREGATE PRINCIPAL AMOUNT AT ANY TIME OUTSTANDING IN RESPECT OF MONEYS BORROWED BY THE GROUP TO EXCEED A SUM EQUAL TO U.S. $12,000,000,000.

 

Management

 

For

 

For

 

 


 

16.

 

THAT THE AUTHORITY TO ALLOT RELEVANT SECURITIES (AS DEFINED IN THE ARTICLES OF ASSOCIATION (“ARTICLES”)) CONFERRED ON THE DIRECTORS BY ARTICLE 10 PARAGRAPH (B) OF THE ARTICLES BE RENEWED AND FOR THIS PURPOSE THE AUTHORISED ALLOTMENT AMOUNT SHALL BE: (A)  9,813,055 OF RELEVANT SECURITIES; AND (B) SOLELY IN CONNECTION WITH AN ALLOTMENT PURSUANT TO AN OFFER BY WAY OF A RIGHTS ISSUE, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

17.

 

THAT SUBJECT TO THE PASSING OF RESOLUTION 16, THE AUTHORITY TO ALLOT EQUITY SECURITIES (AS DEFINED IN THE COMPANY’S ARTICLES OF ASSOCIATION (THE “ARTICLES”)) WHOLLY FOR CASH, CONFERRED ON THE DIRECTORS BY ARTICLE 10 PARAGRAPH (D) OF THE ARTICLES, BE RENEWED AND FOR THIS PURPOSE THE NON PRE-EMPTIVE AMOUNT (AS DEFINED IN THE ARTICLES) SHALL BE 1,494,561 AND THE ALLOTMENT PERIOD SHALL BE THE PERIOD COMMENCING ON APRIL 29, 2014, AND ENDING ON THE EARLIER OF JULY 28, 2015, OR THE CONCLUSION OF THE ANNUAL GENERAL MEETING OF THE COMPANY TO BE HELD IN 2015.

 

Management

 

For

 

For

 

18.

 

THAT THE COMPANY BE AND IS HEREBY GENERALLY AND UNCONDITIONALLY AUTHORIZED: (A) PURSUANT TO ARTICLE 57 OF THE COMPANIES (JERSEY) LAW 1991 TO MAKE MARKET PURCHASES OF ORDINARY SHARES IN THE CAPITAL OF THE COMPANY, AND (B) PURSUANT TO ARTICLE 58A OF THE COMPANIES (JERSEY) LAW 1991, TO HOLD AS TREASURY SHARES ANY ORDINARY SHARES PURCHASED PURSUANT TO THE AUTHORITY CONFERRED BY PARAGRAPH (A) OF THIS RESOLUTION, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

19.

 

TO APPROVE THAT A GENERAL MEETING OF THE COMPANY, OTHER THAN AN ANNUAL GENERAL MEETING, MAY BE CALLED ON NOT LESS THAT 14 CLEAR DAYS’ NOTICE.

 

Management

 

For

 

For

 

 

SUPERNUS PHARMACEUTICALS, INC.

 

Security

868459108

Meeting Type

Annual

Ticker Symbol

SUPN

Meeting Date

22-May-2014

Record Date

31-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

FREDERICK M. HUDSON

 

 

 

For

 

For

 

 

 

2

CHARLES W. NEWHALL, III

 

 

 

For

 

For

 

2.

 

PROPOSAL TO APPROVE THE FLEXIBLE SETTLEMENT FEATURE WITH RESPECT TO FUTURE POTENTIAL CONVERSION OF THE CONVERTIBLE NOTES

 

Management

 

For

 

For

 

3.

 

PROPOSAL TO AMEND THE SUPERNUS PHARMACEUTICALS, INC. 2012 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE UNDER THE PLAN

 

Management

 

For

 

For

 

4.

 

PROPOSAL TO AMEND THE SUPERNUS PHARMACEUTICALS, INC. 2012 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE UNDER THE PLAN

 

Management

 

For

 

For

 

5.

 

PROPOSAL TO RATIFY ERNST & YOUNG, LLP AS THE INDEPENDENT PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014

 

Management

 

For

 

For

 

 


 

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

 

Security

881624209

Meeting Type

Annual

Ticker Symbol

TEVA

Meeting Date

27-Aug-2013

Record Date

25-Jul-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A

 

ELECTION OF DIRECTOR: PROF. MOSHE MANY

 

Management

 

For

 

For

 

1B

 

ELECTION OF DIRECTOR: DR. ARIE BELLDEGRUN

 

Management

 

For

 

For

 

1C

 

ELECTION OF DIRECTOR: MR. AMIR ELSTEIN

 

Management

 

For

 

For

 

1D

 

ELECTION OF DIRECTOR: PROF. YITZHAK PETERBURG

 

Management

 

For

 

For

 

2A

 

TO APPROVE THE PAYMENT OF A CASH BONUS TO THE COMPANY’S PRESIDENT AND CHIEF EXECUTIVE OFFICER IN RESPECT OF 2012 IN AN AMOUNT OF $1,203,125.

 

Management

 

Against

 

Against

 

2A1

 

DO YOU HAVE A “PERSONAL INTEREST” IN PROPOSAL 2A? SEE PAGES 1-2 OF THE PROXY STATEMENT FOR MORE INFORMATION (MARK FOR = “YES” OR AGAINST = “NO”).

 

Management

 

Against

 

 

 

2B

 

TO APPROVE BONUS OBJECTIVES AND PAYOUT TERMS FOR THE YEAR 2013 FOR THE COMPANY’S PRESIDENT AND CHIEF EXECUTIVE OFFICER.

 

Management

 

For

 

For

 

2B1

 

DO YOU HAVE A “PERSONAL INTEREST” IN PROPOSAL 2B? SEE PAGES 1-2 OF THE PROXY STATEMENT FOR MORE INFORMATION (MARK FOR = “YES” OR AGAINST = “NO”).

 

Management

 

Against

 

 

 

3

 

TO APPROVE A COMPENSATION POLICY WITH RESPECT TO THE TERMS OF OFFICE AND EMPLOYMENT OF THE COMPANY’S “OFFICE HOLDERS” (AS SUCH TERM IS DEFINED IN THE ISRAELI COMPANIES LAW, 5759-1999, AS AMENDED).

 

Management

 

For

 

For

 

3A

 

DO YOU HAVE A “PERSONAL INTEREST” IN PROPOSAL 3? SEE PAGES 1-2 OF THE PROXY STATEMENT FOR MORE INFORMATION (MARK FOR = “YES” OR AGAINST = “NO”).

 

Management

 

Against

 

 

 

4

 

TO APPROVE THE RESOLUTION OF THE BOARD OF DIRECTORS TO DECLARE AND DISTRIBUTE THE CASH DIVIDENDS FOR THE FIRST AND SECOND QUARTERS OF THE YEAR ENDED DECEMBER 31, 2012, PAID IN TWO INSTALLMENTS IN AN AGGREGATE AMOUNT OF NIS 2.00 (APPROXIMATELY US$0.51, ACCORDING TO THE APPLICABLE EXCHANGE RATES) PER ORDINARY SHARE (OR ADS).

 

Management

 

For

 

For

 

5

 

TO APPOINT KESSELMAN & KESSELMAN, A MEMBER OF PRICEWATERHOUSECOOPERS INTERNATIONAL LTD., AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM UNTIL THE 2014 ANNUAL MEETING OF SHAREHOLDERS.

 

Management

 

For

 

For

 

 

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

 

Security

881624209

Meeting Type

Special

Ticker Symbol

TEVA

Meeting Date

24-Feb-2014

Record Date

23-Jan-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

TO APPROVE THE COMPENSATION OF MR. EREZ VIGODMAN, THE COMPANY’S PRESIDENT AND CHIEF EXECUTIVE OFFICER-DESIGNATE, AND MATTERS RELATING THERETO.

 

Management

 

For

 

For

 

 


 

THERMO FISHER SCIENTIFIC INC.

 

Security

883556102

Meeting Type

Annual

Ticker Symbol

TMO

Meeting Date

20-May-2014

Record Date

28-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: MARC N. CASPER

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: NELSON J. CHAI

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: C. MARTIN HARRIS

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: TYLER JACKS

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: JUDY C. LEWENT

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: THOMAS J. LYNCH

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: JIM P. MANZI

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: WILLIAM G. PARRETT

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: LARS R. SORENSEN

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: SCOTT M. SPERLING

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: ELAINE S. ULLIAN

 

Management

 

For

 

For

 

2.

 

AN ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

3.

 

RATIFICATION OF THE AUDIT COMMITTEE’S SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT AUDITORS FOR 2014.

 

Management

 

For

 

For

 

 

VENITI, INC.

 

Security

N/A

Meeting Type

Action By Written Consent

Ticker Symbol

N/A

Meeting Date

29-Jan-2014

Record Date

N/A

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

APPROVAL OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION.

 

Management

 

For

 

For

 

2.

 

WAIVER OF PREEMPTIVE RIGHTS AND NOTICE.

 

Management

 

For

 

For

 

3.

 

OMNIBUS RESOLUTIONS.

 

Management

 

For

 

For

 

 

VERASTEM INC

 

Security

92337C104

Meeting Type

Annual

Ticker Symbol

VSTM

Meeting Date

05-May-2014

Record Date

28-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ALISON LAWTON

 

 

 

For

 

For

 

 

 

2

STEPHEN SHERWIN, M.D.

 

 

 

For

 

For

 

 

 

3

TIMOTHY BARBERICH

 

 

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2014.

 

Management

 

For

 

For

 

 

VERTEX PHARMACEUTICALS INCORPORATED

 

Security

92532F100

Meeting Type

Annual

Ticker Symbol

VRTX

Meeting Date

07-May-2014

Record Date

10-Mar-2014

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

MARGARET G. MCGLYNN

 

 

 

For

 

For

 

 

 

2

WAYNE J. RILEY

 

 

 

For

 

For

 

 

 

3

WILLIAM D. YOUNG

 

 

 

For

 

For

 

2.

 

AMENDMENT TO OUR 2013 STOCK AND OPTION PLAN THAT INCREASES THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 9.5 MILLION SHARES.

 

Management

 

For

 

For

 

3.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

4.

 

ADVISORY VOTE ON OUR NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

 


 

WARNER CHILCOTT PUBLIC LIMITED COMPANY

 

Security

G94368100

Meeting Type

Special

Ticker Symbol

WCRX

Meeting Date

10-Sep-2013

Record Date

30-Jul-2013

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

C1

 

APPROVAL OF THE SCHEME OF ARRANGEMENT.

 

Management

 

For

 

For

 

E1

 

APPROVAL OF THE SCHEME OF ARRANGEMENT.

 

Management

 

For

 

For

 

E2

 

CANCELLATION OF WARNER CHILCOTT SHARES PURSUANT TO THE SCHEME OF ARRANGEMENT.

 

Management

 

For

 

For

 

E3

 

DIRECTORS’ AUTHORITY TO ALLOT SECURITIES AND APPLICATION OF RESERVES.

 

Management

 

For

 

For

 

E4

 

AMENDMENT TO ARTICLES OF ASSOCIATION.

 

Management

 

For

 

For

 

E5

 

CREATION OF DISTRIBUTABLE RESERVES OF NEW ACTAVIS.

 

Management

 

For

 

For

 

E6

 

APPROVAL, ON A NON-BINDING ADVISORY BASIS, OF SPECIFIED COMPENSATORY ARRANGEMENTS BETWEEN WARNER CHILCOTT AND ITS NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

E7

 

ADJOURNMENT OF THE EXTRAORDINARY GENERAL MEETING.

 

Management

 

For

 

For

 

 


 

SIGNATURES

 

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

(Registrant)

H&Q Life Sciences Investors

 

By (Signature and Title)*

 

 

 

 

 

 

/s/ Daniel R. Omstead

 

(Daniel R. Omstead, President)

 

Date

8/29/14

 

*Print the name and title of each signing officer under his or her signature.

 

2